Patients with metastatic castration-resistant prostate cancer do not benefit from the addition of Reolysin (pelareorep) to Taxotere (docetaxel), according to recent data... Read More
Cleveland Diagnostics‘ IsoPSA prostate cancer test is significantly better than a standard PSA test at identifying those with prostate cancer and those... Read More
A major problem treating an aggressive form of prostate cancer is that it develops resistance to the androgen therapies used... Read More
A new imaging agent appears capable of distinguishing aggressive from benign prostate cancer, potentially helping doctors select with better precision... Read More
Stereotactic body radiotherapy (SBRT) has shown good long-term outcomes and low rates of severe toxicity, making it a valid treatment... Read More
Three professional societies — the American Urological Association, the American Society for Radiation Oncology and the Society of Urologic Oncology — have issued a... Read More
New guidelines are helping Michigan urologists decide which prostate cancer patients should have computed tomography (CT) scans to see if... Read More
A study supported by Blue Earth Diagnostics showed that physicians can be trained to successfully interpret Axumin PET scan images... Read More
Prostate cancer patients treated with Cesium-131 brachytherapy maintained their urinary- and bowel-related quality of life years afterward, according to a... Read More
A new therapy targeting genomic rearrangements, such as fused genes that promote tumor development, significantly improved survival in mice with... Read More
